Similar articles

• Basic cancer chemotherapy: obstacles and future pharmacologic aspects and selective toxicity.

  Goldin A. Goldin A. Cancer Clin Trials. 1978 Summer;1(2):119-27. Cancer Clin Trials. 1978. PMID: 757140 No abstract available.
• Clinical development of anticancer agents--a National Cancer Institute perspective.

  Marsoni S, Wittes R. Marsoni S, et al. Cancer Treat Rep. 1984 Jan;68(1):77-85. Cancer Treat Rep. 1984. PMID: 6362870 Clinical Trial. No abstract available.
• Experimental models and their clinical correlations.

  Carter SK, Goldin A. Carter SK, et al. Natl Cancer Inst Monogr. 1977 Mar;(45):63-74. Natl Cancer Inst Monogr. 1977. PMID: 927496 No abstract available.
• Combination chemotherapy--theory and practice.

  Capizzi RL, Keiser LW, Sartorelli AC. Capizzi RL, et al. Semin Oncol. 1977 Jun;4(2):227-53. Semin Oncol. 1977. PMID: 327555 Review. No abstract available.
• Camptothecins: from bench research to hospital wards.

  Potmesil M. Potmesil M. Cancer Res. 1994 Mar 15;54(6):1431-9. Cancer Res. 1994. PMID: 8137244 Review. No abstract available.